Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la Base de données des annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Dabigatran or its salts or derivativesPDL

including but not limited to dabigatran etexilate

I DEC / 13
Dabrafenib or its saltsPDL I DEC / 13
DacarbazinePDL I DEC / 13
Daclatasvir or its saltsPDL I OCT / 15
DaclizumabPDL I DEC / 13
Daclizumab betaPDL I FEB / 17
DactinomycinPDL I DEC / 13
Dalfopristin or its saltsPDL I DEC / 13
Dalteparin or its saltsPDL I DEC / 13
Danaparoid or its salts or derivativesPDL I DEC / 13
DanazolPDL I DEC / 13
Danofloxacin or its saltsPDL I DEC / 13
Danthron III SEP / 98
Dantrolene or its saltsPDL I DEC / 13
Dapagliflozin or its derivativesPDL I MAR / 15
Dapiprazole or its saltsPDL I DEC / 13
DaptomycinPDL I DEC / 13
DaratumumabPDL I AUG / 16
Darifenacin or its saltsPDL I DEC / 13
DarunavirPDL I DEC / 13
Dasabuvir or its saltsPDL I MAR / 15
DasatanibPDL I DEC / 13
Daunorubicin or its saltsPDL I DEC / 13
Debrisoquin or its saltsPDL I DEC / 13
DeferasiroxPDL I DEC / 13
Deferiprone or its derivativesPDL I MAR / 15
Deferoxamine or its saltsPDL I DEC / 13
Defibrotide or its salts or derivativesPDL I SEP / 17
Degarelix or its salts or derivativesPDL I DEC / 13
Dehydrocholic acid and its salts III SEP / 98
Delavirdine or its saltsPDL I DEC / 13
DelorazepamTS I JUN / 02
DenosumabPDL I DEC / 13
Deoxycholic acid or its saltsPDL

when used in an injectable form

I OCT / 15
Deoxycholic acid or its salts.

except when used in an injectable form

III OCT / 15
DeracoxibPDL I DEC / 13
Derquantel or its saltsPDL

for veterinary use

I AUG / 16
Deserpidine or its alkaloids or saltsPDL I DEC / 13
DesfluranePDL I DEC / 13
Desipramine or its saltsPDL I DEC / 13
Desloratadine and its salts and preparations. in products marketed for paediatric use - under 12 years of age III SEP / 05
Desloratadine and its salts and preparations.

in products marketed for adult use - 12 years and older

U SEP / 05
Desmopressin or its saltsPDL I DEC / 13
DesomorphineN I JUN / 02
Desoxyribonuclease [pancreatic dornase] II SEP / 98
Desvenlafaxine or its saltsPDL

including but not limited to desvenlafaxine succinate

I DEC / 13
Detomidine or its saltsPDL I DEC / 13
Dexbrompheniramine and its salts III SEP / 98
Dexchlorpheniramine and its salts III SEP / 98
Dexrazoxane or its saltsPDL I DEC / 13
Dextromethorphan and its salts except in oral dosage forms in package sizes containing no more than 300mg DM base or 409.3 DM hydrobromide III AUG / 02
Dextromethorphan and its salts. in oral dosage forms in package sizes containing no more than 300 mg DM base or 409.3 DM hydrobromide U AUG / 02
DextromoramideN I JUN / 02
DextropropoxypheneN I JUN / 02
Dextrose sclerosing agents II SEP / 98
Dextrose injection concentrated solutions for parenteral injection I JAN / 03
DiampromideN I JUN / 02
Diazepam and its saltsTS I SEP / 98
Diazoxide or its saltsPDL I DEC / 13
Dibotermin alfaPDL

for veterinary use

I FEB / 14
Dichloroacetic acidPDL I DEC / 13
Diclofenac diethylamine when sold as a single medicinal ingredient for topical use on the skin for not more than 7 days - in concentrations greater than 1.16% and less than or equal to 2.32% - in package sizes containing greater than 2.6g of diclofenac diethylamine II AUG / 14
Diclofenac diethylamine.

when sold as a single medicinal ingredient for topical use on the skin for not more than 7 days - in concentrations greater than 1.16% and less than or equal to 2.32% - in package sizes containing no more than 2.6g of diclofenac diethylamine

III AUG / 14
Diclofenac diethylamine..

when sold as a single medicinal ingredient for topical use on the skin in concentrations of not more than 1.16% for not more than 7 days

U AUG / 14
Diclofenac or its saltsPDL

including (but not limited to): diclofenac diethylamine, diclofenac sodium, diclofenac potassium, except when sold as a single medicinal ingredient for topical use on the skin in a concentration equivalent to 2% or less of diclofenac for not more than 7 days

I AUG / 14
Dicyclomine and its salts except for topical use and lozenges II SEP / 98
Didanosine or its salts or derivativesPDL I DEC / 13
DiethylbromacetamidePDL I DEC / 13
Diethylcarbamazine or its saltsPDL I DEC / 13
Diethylpropion and any salt thereofC2 I JUN / 02
Diethylstilbestrol or its salts or derivativesPDL I DEC / 13
DiethylthiambuteneN I JUN / 02
DifenoxinN I JUN / 02
Difloxacin or its salts or derivativesPDL I DEC / 13
Diflunisal or its saltsPDL I DEC / 13
Digestive enzymes from plant sources U SEP / 99
Digoxin immune FabPDL

ovine

I DEC / 13
DihydrocodeineN I JUN / 02
DihydromorphineN I JUN / 02
Dihydroquinidine and its salts except phenylbarbiturate II SEP / 98
Dihydrostreptomycin or its salts or derivativesPDL

for veterinary use

I DEC / 13
DihydrotachysterolPDL

for human use

I DEC / 13
DiiodohydroxyquinPDL

except in preparations for topical use on the skin

I DEC / 13
Diiodohydroxyquin

for topical use on the skin

II SEP / 98
Diltiazem or its saltsPDL I DEC / 13
Dimenhydrinate and its salts for parenteral use II SEP / 98
Dimenhydrinate and its salts. for oral or rectal use [Note: Pharmacists are advised that in areas where there is evidence of abuse or particular concern about abuse, dimenhydrinate products should not be located in a self-selection area of the pharmacy]. III APR / 99
DimenoxadolN I JUN / 02
DimepheptanolN I JUN / 02
DimercaprolPDL I DEC / 13
Dimethothiazine III SEP / 98
Dimethyl sulfoxidePDL

for veterinary use or when sold for the treatment of interstitial cystitis or scleroderma in humans

I DEC / 13
DimethylaminodiphenylbutanonitrileN I JUN / 02
DimethylfumaratePDL I DEC / 13
DimethylthiambuteneN I JUN / 02
Dimeticone 100 cSt solution 50% w/w for topical use in the treatment of head lice III JAN / 13
Dinitrophenol or its salts or derivativesPDL I DEC / 13
Dioxaphetyl butyrateN I JUN / 02
Diperodon and its salts except for topical use II SEP / 98
Diphenhydramine and its salts and preparations for parenteral use II SEP / 98

149 résultats


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations}
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drus Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled